IOVA ev to operating cash flow history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Iovance Biotherapeutics Inc EV to Operating Cash Flow — Quarterly
Period ending	EV to Operating Cash Flow
Jun 30, 2026	-29.7172×
Mar 31, 2026	-18.3179×
Dec 31, 2025	-18.9553×
Sep 30, 2025	-8.6951×
Jun 30, 2025	-7.3548×
Mar 31, 2025	-9.231×
Dec 31, 2024	-29.9983×
Sep 30, 2024	-46.8426×
Jun 30, 2024	-21.8285×
Mar 31, 2024	-30.4864×
Dec 31, 2023	-24.3165×
Sep 30, 2023	-11.0632×
Jun 30, 2023	-15.2317×
Mar 31, 2023	-8.4698×
Dec 31, 2022	-11.6718×
Sep 30, 2022	-23.1525×
Jun 30, 2022	-22.0095×
Mar 31, 2022	-35.2764×
Dec 31, 2021	-55.5064×
Sep 30, 2021	-66.708×
Jun 30, 2021	-73.5096×
Mar 31, 2021	-73.5327×
Dec 31, 2020	-108.1726×
Sep 30, 2020	-117.6136×
Jun 30, 2020	-95.6068×
Mar 31, 2020	-57.3795×
Dec 31, 2019	-64.8948×
Sep 30, 2019	-52.9357×
Jun 30, 2019	-88.2384×
Mar 31, 2019	-40.1418×
Dec 31, 2018	-30.8013×
Sep 30, 2018	-34.9656×
Jun 30, 2018	-37.9971×
Mar 31, 2018	-63.2211×
Dec 31, 2017	-20.8443×
Sep 30, 2017	-15.2683×
Jun 30, 2017	-19.7059×
Mar 31, 2017	-16.8502×
Dec 31, 2016	-21.822×
Sep 30, 2016	-32.2389×
Jun 30, 2016	-83.3891×
Mar 31, 2016	-52.2146×
Dec 31, 2015	-36.3498×
Sep 30, 2015	-68.1884×
Jun 30, 2015	-89.0782×
Mar 31, 2015	-99.7535×
Dec 31, 2014	-75.9065×
Sep 30, 2014	-100.2082×
Jun 30, 2014	-102.892×
Mar 31, 2014	-78.677×
Dec 31, 2013	-15.8415×
Sep 30, 2013	-11.7038×
Jun 30, 2013	-1.5662×
Mar 31, 2013	-38.997×
Dec 31, 2012	3.6816×
Sep 30, 2012	-134.6214×
Jun 30, 2012	-34.5123×
Mar 31, 2012	-124.7997×
Dec 31, 2011	-30.4933×
Sep 30, 2011	-48.4918×
Jun 30, 2011	-84.6509×
Mar 31, 2011	-151.643×
Dec 31, 2010	-239.8017×
Sep 30, 2010	-691.9013×
Jun 30, 2010	-958.2218×
Mar 31, 2010	-1,824.1668×
Dec 31, 2009	-10,236.494×
Sep 30, 2009	-249,222.7276×
Jun 30, 2009	-322,663.8792×
Mar 31, 2009	-99,912.0658×
Dec 31, 2008	-9,643.7564×
Sep 30, 2008	-135,189.5223×
Jun 30, 2008	-9,205.1178×
Mar 31, 2008	-4,776.8707×